Question 1

Does Point72 Asset Management own MNPR stock?

Accepted Answer

No. Point72 Asset Management exited its MNPR (Monopar Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 104,019 shares worth $3.7M.

Question 2

How many shares of MNPR does Point72 Asset Management own?

Accepted Answer

None since Q3 2025, when Point72 Asset Management exited the position. Its Q2 2025 13F listed 104,019 shares worth $3.7M.

Question 3

What is Point72 Asset Management's MNPR position worth?

Accepted Answer

Point72 Asset Management's MNPR position was worth $3.7M in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Point72 Asset Management buying or selling MNPR?

Accepted Answer

In Q3 2025, Point72 Asset Management exited its entire MNPR position.

Question 5

When did Point72 Asset Management first buy MNPR?

Accepted Answer

Point72 Asset Management first reported MNPR in its Q4 2024 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$75.90	0
2025-Q2	Decreased	104,019	-38.1%	$3.7M	0.0%	$33.60	0
2025-Q1	Increased	168,160	+0.2%	$6.1M	0.0%	$40.33	27
2024-Q4	New	167,892	—	$3.7M	0.0%	$23.85	37